Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Daewoong's P-CAB Contender Holds Up Well At Phase III
Non-Inferior To Esomeprazole
May 11 2020
•
By
Jung Won Shin
Daewoong Aims To Position Fexuprazan As Best-In-Class GERD Option • Source: Shutterstock
More from South Korea
More from Focus On Asia